ducovest

FXH:ARCA-First Trust Health Care AlphaDEX (USD)

ETF | Health | NYSE Arca

Last Closing

USD 109.59

Change

+0.26 (+0.24)%

Market Cap

USD 0.92B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant(R) Health Care Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is a modified equal-dollar weighted index designed by NYSE to objectively identify and select stocks from the Russell 1000(R) Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX(R) selection methodology.

Company Website : www.ftportfolios.com

Currency: USD

Country : USA

Inception Date: 08/05/2007

Primary Benchmark: StrataQuant Health Care TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.61%

Management Expense Ratio: 0.63 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
3020-OL:HK X DBMSCIUSA 2.13 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

N/A

 USD 37.76B
VHT Vanguard Health Care Index Fun.. 0.10 %

N/A

 USD 16.98B
XBI SPDR® S&P Biotech ETF 0.35 %

N/A

 USD 7.05B
IHI iShares U.S. Medical Devices E.. 0.43 %

N/A

 USD 5.55B
IXJ iShares Global Healthcare ETF 0.46 %

N/A

 USD 4.11B
IYH iShares U.S. Healthcare ETF 0.43 %

N/A

 USD 3.23B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

N/A

 USD 2.94B
FBT First Trust NYSE Arca Biotechn.. 0.57 %

N/A

 USD 1.08B
IHF iShares U.S. Healthcare Provid.. 0.43 %

N/A

 USD 0.82B
IHE iShares U.S. Pharmaceuticals E.. 0.42 %

N/A

 USD 0.69B

ETFs Containing FXH

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.83% 50% F 61% D-
Dividend Return 0.10% 31% F 4% F
Total Return 5.94% 50% F 57% F
Trailing 12 Months  
Capital Gain 3.47% 18% F 39% F
Dividend Return 0.29% 32% F 3% F
Total Return 3.76% 18% F 30% F
Trailing 5 Years  
Capital Gain 43.42% 55% F 68% D+
Dividend Return 0.75% 32% F 2% F
Total Return 44.17% 55% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 8.66% 64% D 69% C-
Dividend Return 8.74% 59% D- 64% D
Total Return 0.08% 30% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 17.54% 50% F 63% D
Risk Adjusted Return 49.84% 59% D- 77% C+
Market Capitalization 0.92B 68% D+ 57% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.